103 related articles for article (PubMed ID: 18499236)
21. Effect of palm-based tocotrienols and tocopherol mixture supplementation on platelet aggregation in subjects with metabolic syndrome: a randomised controlled trial.
Gan YL; Fu JY; Lai OM; Chew BH; Yuen KH; Teng KT; Nesaretnam K; Selvaduray KR; Meganathan P
Sci Rep; 2017 Sep; 7(1):11542. PubMed ID: 28912593
[TBL] [Abstract][Full Text] [Related]
22. Evaluating platelet aggregation dynamics from laser speckle fluctuations.
Hajjarian Z; Tshikudi DM; Nadkarni SK
Biomed Opt Express; 2017 Jul; 8(7):3502-3515. PubMed ID: 28717586
[TBL] [Abstract][Full Text] [Related]
23. Point-of-care testing in the acute management of traumatic brain injury: Identifying the coagulopathic patient.
Gozal YM; Carroll CP; Krueger BM; Khoury J; Andaluz NO
Surg Neurol Int; 2017; 8():48. PubMed ID: 28480110
[TBL] [Abstract][Full Text] [Related]
24. Utility of the Aspirin and P2Y12 Response Assays to Determine the Effect of Antiplatelet Agents on Platelet Reactivity in Traumatic Brain Injury.
Parry PV; Choi PA; Bauer JS; Panczykowski DM; Puccio AM; Okonkwo DO
Neurosurgery; 2017 Jan; 80(1):92-96. PubMed ID: 28362884
[TBL] [Abstract][Full Text] [Related]
25. Use of Aspirin and P2Y12 Response Assays in Detecting Reversal of Platelet Inhibition With Platelet Transfusion in Patients With Traumatic Brain Injury on Antiplatelet Therapy.
Choi PA; Parry PV; Bauer JS; Zusman BE; Panczykowski DM; Puccio AM; Okonkwo DO
Neurosurgery; 2017 Jan; 80(1):98-104. PubMed ID: 28362883
[TBL] [Abstract][Full Text] [Related]
26. New single-nucleotide polymorphisms associated with differences in platelet reactivity and their influence on survival in patients with type 2 diabetes treated with acetylsalicylic acid: an observational study.
Milanowski L; Pordzik J; Janicki PK; Kaplon-Cieslicka A; Rosiak M; Peller M; Tyminska A; Ozieranski K; Filipiak KJ; Opolski G; Mirowska-Guzel D; Postula M
Acta Diabetol; 2017 Apr; 54(4):343-351. PubMed ID: 27995340
[TBL] [Abstract][Full Text] [Related]
27. Neurointerventional Stenting and Antiplatelet Function Testing: To Do or Not to Do?
Kass-Hout T; Alderazi YJ; Amuluru K; Jin P; Ayala C; Prestigiacomo C; Gandhi CD
Interv Neurol; 2015 Jul; 3(3-4):184-9. PubMed ID: 26279665
[TBL] [Abstract][Full Text] [Related]
28. The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin.
Neergaard-Petersen S; Hvas AM; Grove EL; Larsen SB; Gregersen S; Kristensen SD
PLoS One; 2015; 10(7):e0132629. PubMed ID: 26148094
[TBL] [Abstract][Full Text] [Related]
29. The effect of different doses and different routes of acetylsalicylic acid administration on platelet aggregation in healthy volunteers and ischemic stroke patients.
Chýlová M; Moťovská Z; Osmančík P; Procházka B; Kalvach P
Transl Stroke Res; 2015 Apr; 6(2):160-5. PubMed ID: 25524214
[TBL] [Abstract][Full Text] [Related]
30. Aspirin resistance: a clinical review focused on the most common cause, noncompliance.
Schwartz KA
Neurohospitalist; 2011 Apr; 1(2):94-103. PubMed ID: 23983843
[TBL] [Abstract][Full Text] [Related]
31. Effect of common single-nucleotide polymorphisms in acetylsalicylic acid metabolic pathway genes on platelet reactivity in patients with diabetes.
Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Kondracka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
Med Sci Monit; 2013 May; 19():394-408. PubMed ID: 23715170
[TBL] [Abstract][Full Text] [Related]
32. Effect of premedication method and drug resistance of antiplatelet agent on periprocedural thromboembolic events during coil embolization of an unruptured intracranial aneurysm.
Park SH; Kim YB; Huh SK
J Cerebrovasc Endovasc Neurosurg; 2012 Sep; 14(3):148-56. PubMed ID: 23210040
[TBL] [Abstract][Full Text] [Related]
33. New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy.
Postula M; Janicki PK; Rosiak M; Kaplon-Cieslicka A; Trzepla E; Filipiak KJ; Kosior DA; Czlonkowski A; Opolski G
J Thromb Thrombolysis; 2013 Jul; 36(1):65-73. PubMed ID: 23054467
[TBL] [Abstract][Full Text] [Related]
34. Assessment of platelet inhibition by point-of-care testing in neuroendovascular procedures.
Hussein HM; Emiru T; Georgiadis AL; Qureshi AI
AJNR Am J Neuroradiol; 2013 Apr; 34(4):700-6. PubMed ID: 22422188
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet resistance and thromboembolic complications in neurointerventional procedures.
Oxley TJ; Dowling RJ; Mitchell PJ; Davis S; Yan B
Front Neurol; 2011; 2():83. PubMed ID: 22363312
[TBL] [Abstract][Full Text] [Related]
36. Personalized vascular medicine: individualizing drug therapy.
Degoma EM; Rivera G; Lilly SM; Usman MH; Mohler ER
Vasc Med; 2011 Oct; 16(5):391-404. PubMed ID: 22003003
[TBL] [Abstract][Full Text] [Related]
37. Effect of gender difference on platelet reactivity.
Breet NJ; Sluman MA; van Berkel MA; van Werkum JW; Bouman HJ; Harmsze AM; Kelder JC; Zijlstra F; Hackeng CM; Ten Berg JM
Neth Heart J; 2011 Nov; 19(11):451-7. PubMed ID: 21901505
[TBL] [Abstract][Full Text] [Related]
38. Aspirin resistance.
Mansour K; Taher AT; Musallam KM; Alam S
Adv Hematol; 2009; 2009():937352. PubMed ID: 19960045
[TBL] [Abstract][Full Text] [Related]
39. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
[TBL] [Abstract][Full Text] [Related]
40. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
